Related Experiment Videos
Rationale for using recombinant human erythropoietin to treat the anemia of prematurity
R H Phibbs1, K Shannon, W C Mentzer
1Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco.
Contributions to Nephrology
|January 1, 1989
Abstract
No abstract available in PubMed .